文献速递类风湿关节炎

滑膜成纤维细胞脂解增强标志RA高风险个体早期致病变化

Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals.
PubMed 文献 · Ann Rheum Dis · 2026-05-30

研究比较RA高风险个体、RA患者、骨关节炎(OA)患者及非炎性骨科损伤对照的滑膜成纤维细胞(SF),发现RA和RA风险SF转录谱异常且脂滴含量降低,源于G0S2表达下降导致的脂解增强,可被ATGL抑制逆转,提示早期脂代谢改变先于临床关节炎。

要点

  • RA高风险个体滑膜成纤维细胞已出现脂代谢转录异常和脂滴减少。
  • 脂滴减少源于G0S2下调导致的脂解增强,可被ATGL抑制逆转。
  • 刺激G0S2表达可减少SF的髓系支持表型。

核心结论

  • 滑膜成纤维细胞早期脂代谢改变先于临床关节炎出现,是RA进展的重要细胞功能变化。

研究设计与样本

  • 比较RA高风险个体、RA患者、OA患者及年龄匹配非炎性骨科损伤对照的滑膜成纤维细胞转录组和脂代谢。

主要发现

  • RA和RA风险SF转录谱与对照不同,包括脂代谢失调。
  • RA、RA风险和OA的SF基线脂滴含量均低于对照,但RA和RA风险SF的脂滴减少源于脂解增强。
  • RA和RA风险SF脂解增强可能与G0S2表达下降有关,可被脂肪甘油三酯脂肪酶抑制逆转。
  • 刺激G0S2表达伴随SF髓系支持表型减少。

临床怎么用

  • RA高风险个体滑膜成纤维细胞的脂代谢改变可作为早期干预的潜在靶点方向。

局限性

  • 研究为体外细胞比较,未报告样本量、具体统计值及临床随访细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by synovial inflammation and progressive joint destruction, driven in part by the aggressive behaviour of synovial fibroblasts (SFs). Emerging evidence suggests that metabolic dysfunction in SFs contributes to RA pathogenesis. Studying autoantibody-positive at-risk individuals who have not yet developed clinical arthritis (RA-risk) offers a unique opportunity to investigate early disease mechanisms. Our previous work identified a transcriptional downregulation of genes involved in lipid and fatty acid metabolism in synovium samples of RA-risk individuals who later developed RA, even in the absence of overt immune cell infiltration. Here, we hypothesised that these alterations reflect an early metabolic shift in SFs. METHODS: To investigate this, we compared transcriptomic profiles and lipid metabolism in SFs from RA-risk individuals, patients with RA and osteoarthritis (OA), and age-matched noninflammatory orthopaedic injury controls. RA and RA-risk SFs displayed distinct transcriptional signatures compared with controls, including dysregulation of lipid metabolism. RESULTS: Despite retained adipogenic differentiation potential, RA, RA-risk, and OA SFs showed reduced baseline lipid droplet (LD) content compared with controls. In RA and RA-risk SFs, this reduction was a result of enhanced LD lipolysis, plausibly as a result of decreased G0S2 expression, and could be reversed by adipose triglyceride lipase inhibition. Furthermore, stimulating G0S2 expression coincided with a reduced myeloid-supporting SF phenotype. CONCLUSIONS: Overall, these findings suggest that early lipid metabolic alterations in SFs represent important shifts in cellular function that precedes clinical disease and highlight the need to further interrogate the role of lipid metabolism in RA progression.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Jiménez-Martínez M, de Jong TA, Houtman M, et al. Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals. Ann Rheum Dis. 2026. PMID: 42215375. doi:10.1016/j.ard.2026.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。